Laurie Toich, Assistant Editor

ASCO is conducting a clinical trial to evaluate how different targeted cancer drugs work to find additional uses outside its FDA indication.

Patients with lung cancer who reported symptoms via Moovcare showed 1-year survival of 75%.

Choosing Wisely recommendations have not substantially changed the care received by patients in the last 30 days of life.

Access to new cancer medications varies greatly by country.

Insulin plus metformin was seen to lower the risk of death and major cardiac events in patients with type 2 diabetes.

A 5-step sequential process for identifying Alzheimer’s disease biomarkers has been created.

Top news of the day from across the healthcare landscape.

Patients with COPD have less access to care, higher treatment costs, and lower standards of care.

Immunotherapy combination increased T cell activity in the blood and the patient went into remission.

Denmark is close to eradicating HIV through a prevention approach.

Approximately 45% of female patients with atrial fibrillation did not receive blood thinning treatment to prevent strokes.

Rovalpituzumab tesirine reduced tumor growth and even shrank tumors in some patients with small cell lung cancer.

Patients treated with chemotherapy and IMAB362 had a median overall survival of 16.7 months.

Patients treated with atezolizumab had a longer median overall survival than patients treated with carboplatin-based regimens.

Male mice that ate 10.5% of their calories in walnuts had 2.3 times less tumors.

The drug 16-8 was able to stop abdominal pain from pancreas inflammation in mice.

Patients receiving intraperitoneal and intravenous chemotherapy had progression-free survival of 59.3 months.

Precision medicine found to be associated with increased tumor reduction and progression-free survival.

The amount public health insurance programs reimburse for new cancer drugs varies in different countries.

Websites and apps can offer discounts for most drugs, but many Americans still are not using them.

Access to new cancer medications varies greatly by country.

Overall 3-year survival in patients with advanced melanoma taking pembrolizumab was 40%.

Generic injectable drugs can cause shortages due to high manufacturing costs and low profit margins.

Dystrophic muscle shows high levels of an enzyme that impairs muscle repair.

A dietary supplement was found to reverse brain cell loss and prevent cognitive decline in mice.

Top news of the day from across the healthcare landscape.

The VA has been portrayed poorly in the media, but some veterans report no issues with their healthcare.

Increased education could lead to a decrease in opioid-related abuse and deaths.

Family caregivers of patients with terminal cancers could benefit from early palliative care.

Many drugs approved from 2009 to 2014 did not have formal analyses of the surrogate-survival correlation.